Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor

Bcg Immunotherapy ◽

Intravesical Bcg ◽

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer

PLoS ONE ◽

10.1371/journal.pone.0189354 ◽

2017 ◽

Vol 12 (12) ◽

pp. e0189354 ◽

Cited By ~ 2

Author(s):

Bum Sik Tae ◽

Chang Wook Jeong ◽

Cheol Kwak ◽

Hyeon Hoe Kim ◽

Kyung Chul Moon ◽

...

Keyword(s):

Bladder Cancer ◽

Risk Factor ◽

High Risk ◽

Transurethral Resection ◽

Bladder Tumor ◽

Invasive Bladder Cancer ◽

Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?

PLoS ONE ◽

10.1371/journal.pone.0208267 ◽

2018 ◽

Vol 13 (11) ◽

pp. e0208267 ◽

Cited By ~ 2

Author(s):

Hyeong Dong Yuk ◽

Chang Wook Jeong ◽

Cheol Kwak ◽

Hyeon Hoe Kim ◽

Ja Hyeon Ku

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Bladder Tumor ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.04.023 ◽

2020 ◽

Vol 38 (10) ◽

pp. 795.e9-795.e17

Author(s):

Naoki Fujita ◽

Shingo Hatakeyama ◽

Masaki Momota ◽

Yuki Tobisawa ◽

Tohru Yoneyama ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Bladder Tumor ◽

Invasive Bladder Cancer ◽

Oncological Outcomes ◽

Primary complete transurethral resection of bladder tumor using photodynamic diagnosis for high-risk non-muscle invasive bladder cancer: Is second-look TURBT mandatory?

European Urology ◽

10.1016/s0302-2838(21)01136-2 ◽

2021 ◽

Vol 79 ◽

pp. S1051

Author(s):

A. Tadrist ◽

M. Baboudjian ◽

B. Gondran-Tellier ◽

G. Karsenty ◽

E. Lechevallier ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Bladder Tumor ◽

Invasive Bladder Cancer ◽

Photodynamic Diagnosis ◽

Second Look ◽

Primary Complete Transurethral Resection of Bladder Tumor using Photodynamic Diagnosis for High-risk Non-Muscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?

Journal of Endourology ◽

10.1089/end.2020.1107 ◽

2021 ◽

Author(s):

Abel Tadrist ◽

Bastien Gondran-Tellier ◽

Robin McManus ◽

Khalid Al-Balushi ◽

Akram Akiki ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Bladder Tumor ◽

Invasive Bladder Cancer ◽

Photodynamic Diagnosis ◽

A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3305-x ◽

2017 ◽

Vol 79 (6) ◽

pp. 1099-1107 ◽

Cited By ~ 4

Author(s):

Feng Sun ◽

Ruizhe Zhao ◽

Yiyong Zhu ◽

Di Cui ◽

Xiaohai Wang ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Thulium Laser ◽

Prospective Comparison ◽

Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study

European Urology ◽

10.1016/j.eururo.2017.12.007 ◽

2018 ◽

Vol 73 (4) ◽

pp. 636 ◽

Cited By ~ 1

Author(s):

Karl H. Pang ◽

Aidan P. Noon

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Radical Cystectomy ◽

Feasibility Study ◽

Invasive Bladder Cancer ◽

Bcg Immunotherapy ◽

Intravesical Bcg ◽

Muscle Invasive ◽

Randomised Controlled

Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.03.025 ◽

2021 ◽

Author(s):

Jamie S Pak ◽

Christopher R Haas ◽

Christopher B Anderson ◽

G Joel DeCastro ◽

Mitchell C Benson ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Transurethral Resection ◽

Bladder Tumor ◽

Oncologic Outcomes ◽

Invasive Bladder Cancer ◽

Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens

PLoS ONE ◽

10.1371/journal.pone.0204745 ◽

2018 ◽

Vol 13 (9) ◽

pp. e0204745 ◽

Cited By ~ 4

Author(s):

Ryosuke Murai ◽

Yasushi Itoh ◽

Susumu Kageyama ◽

Misako Nakayama ◽

Hirohito Ishigaki ◽

...

Keyword(s):

Bladder Cancer ◽

T Cells ◽

Transurethral Resection ◽

Bladder Tumor ◽

Invasive Bladder Cancer ◽

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin

BJU International ◽

10.1111/bju.13102 ◽

2015 ◽

Vol 116 (5) ◽

pp. 721-726 ◽

Cited By ~ 17

Author(s):

Sümer Baltacı ◽

Murat Bozlu ◽

Asıf Yıldırım ◽

Mehmet İlker Gökçe ◽

İlker Tinay ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽